Acta Med. 2004, 47: 125-128

https://doi.org/10.14712/18059694.2018.77

The Detection of Urinal Neopterin Concentration Increases the Efficiency of Cervical Smear in the Diagnosis of Cervical Cancer

Merih Bayrama, Hakan Boyunagab, Kemal Diribasc, Guler Ozera, Emin Ozgur Akguld, M Kemal Erbild

aKirikkale University, Faculty of Medicine, Department of Obstetrics and Gynecology, Kirikkale, Turkey
bKirikkale University, Faculty of Medicine, Department of Biochemistry, Kirikkale, Turkey
cKalecik State Hospital, Department of Gynecology and Obstetrics, Kirikkale, Turkey
dAcademy of Gulhane Ministry Medical, Department of Biochemistry and Clinic Biochemistry, Ankara, Turkey

Received November 1, 2003
Accepted February 1, 2004

References

1. Bozkurt S. Jinekolojik onkolojide servikovaginal sitoloji. Jinekolojik Onkoloji, ed.: Atasü T,Aydinli K.Logos Yay.Istanbul-Turkey,1999:190–220.
2. Brown AE, Dance DA, Chaowagul W, Webster HK, White NJ. Activation of cellular immune responses in melioidosis patients as assessed by urinary neopterin. Trans R Soc Trop Med Hyg 1990; 84(4):583–4. <https://doi.org/10.1016/0035-9203(90)90049-K>
3. Brown GM. The biosynthesis of pteridines. Adv Enzymol. 1971; 35:5–77.
4. Fredrikson S, Link H, Eneroth P. CSF neopterin as marker of disease activity in multiple sclerosis. Acta Neurol Scand 1987; 75(5):352–5. <https://doi.org/10.1111/j.1600-0404.1987.tb05458.x>
5. Fuchs D, Hausen A, Kofler M, Kosanowski H, Reibnegger G, Wachter H. Neopterin as an index of immune response in patients with tuberculosis. Lung 1984; 162;337–46. <https://doi.org/10.1007/BF02715666>
6. Fuchs D, Hausen A, Reibnegger G, Werner ER, Dierich MP, Wachter H. Neopterin as a marker for activated cell-mediated immunity:Application in HIV infection. Immunol Today 1989; 9:150–5. <https://doi.org/10.1016/0167-5699(88)91203-0>
7. Griffin DE, Ward BJ, Jauregui E, Johnson RT, Vaisberg A. Immune activation during measles:Interferon- gamma and neopterin in plasma and cerebrospinal fluid in complicated and uncomplicated disease. J Infect Dis 1990; 161(3): 449–53. <https://doi.org/10.1093/infdis/161.3.449>
8. Hurt WG, Silverberg SG, Frable WJ, Belgrad R, Crooks LD. Adenocarcinoma of cervix: histopathologic and clinical features. Am J Obstet Gynecol 1977; 129(3):304–15. <https://doi.org/10.1016/0002-9378(77)90788-8>
9. Kern P, Rokos H, Dietrich M. Raised serum levels and imbalances of T-lymphocyte subsets in viral diseases,acquired immune deficiency and related lymphadenopathy syndromes. Biomed Pharmacother 1984; 38(8):407–11.
10. Mayersbach P, Augustin R, Schennach H et al. Commercial enzyme-linked immunosorbent assay for neopterin detection in blood donations compared with RIA and HPLC. Clin Chem 1994; 40(2):265–6.
11. Nassonov EL, Samsonov MY, Tilz GP et al. Serum concentrations of neopterin, soluble interleukin-2 receptor and soluble tumor necrosis factor receptor in Wegener’s granulomatosis. J Rheumatol 1997; 24(4):666–70.
12. Papanicolau GN. New cancer diagnosis. “Proceedings of the Third Race Betterment Conference”. New York,1928.
13. Park IS, Lee YS, Kim JC, Hwang SG. Serum neopterin levels in ovarian tumors. Int J Gynaecol Obstet 1995; 51(3):229–34. <https://doi.org/10.1016/0020-7292(95)80010-7>
14. Reibnegger G, Auhuber I, Fuchs Det al. Urinary neopterin levels in acute viral hepatitis. Hepatology 1988; 8(4):771–4. <https://doi.org/10.1002/hep.1840080412>
15. Reibnegger G, Bichler A, Dapunt O et al. Neopterin as a prognostic indicator in patients with carcinoma of the uterine cervix. Cancer Res 1986; 46(2):950–5.
16. Reibnegger G, Boonpucknavig V, Fuchs D, Hausen A, Schmutzhard E, Wachter H. Urinary neopterin is elevated in patients with malaria. Trans Roy Soc Trop Med Hyd 1984; 78:545–6. <https://doi.org/10.1016/0035-9203(84)90080-4>
17. Reibnegger G, Egg D, Fuchs D et al. Urinary neopterin reflects clinical activity in patients with rheumatoid arthritis. Arthritis Rheum 1986; 29(9):1063–70. <https://doi.org/10.1002/art.1780290902>
18. Reibnegger G, Fuchs D, Fuith LC et al. Neopterin as a marker for activated cellmediated immunity:Application in malignant disease. Cancer Detect Prevent 1991; 15(6):483–90.
19. Reibnegger G, Hetzel H, Fuchs D et al. Clinical significance of neopterin for prognosis and follow-up in ovarian cancer. Cancer Res 1987; 47(18):4977–81.
20. Rembold H, Buschmann L. Struktur und synthese des neopterins. Chem Ber 1963; 96:1406–10. <https://doi.org/10.1002/cber.19630960532>
21. Sakurai A, Goto M. Neopterin: isolation from human urine. J Biochem 1967; 61:142–5. <https://doi.org/10.1093/oxfordjournals.jbchem.a128513>
22. Samsonov MY, Tilz GP, Egorova O et al. Serum soluble markers of immune activation and disease activity in systemic lupus erythematosus. Lupus 1995; 4(1); 29–32. <https://doi.org/10.1177/096120339500400107>
23. Schmutzhard E, Fuchs D, Haussen A, Reibnegger G, Wachter H. Is neopterin - a marker of cell mediated immune response - helpful in classifying leprosy? East Afr Med J 1986; 63(9):577–80.
24. Wachter H, Hausen A, Graněmecká betamayr K. Erhöhte Ausscheidung von Neopterin im Harn von Patienten mit malignen Tumoren und mit Viruserkrankungen. Hoppe-Seyler’s Z Physiol Chem 1979; 360:1957–60.
25. Weiss G, Fuchs D, Hausen A et al. Neopterin modulated toxicity mediated by reactive oxygen and chloride species. FEBS Lett 1993; 321(1):89–92. <https://doi.org/10.1016/0014-5793(93)80627-7>
26. Werner ER, Bichler A, Daxenbichler G et al. Determination of neopterin in serum and urine. Clin Chem 1987; 33(1):62–6.
27. Zwingenberger K, Harms G, Feldmeier H, Muller O, Steiner A, Bienzle U. Liver involvement in human schistosomiasis mansoni.Regression of immunological and biochemical disease markers after specific treatment. Acta Tropica 1988; 45(3):263–75.
front cover

ISSN 1211-4286 (Print) ISSN 1805-9694 (Online)

Open access journal

Archive